Table 3. Association between post-vaccination infection and anti-Spike antibody levels within TwinsUK.
Q2 antibody level | Post-vaccination infection incidence rate (%) | UnadjustedOR (95% CI), p-value | Adjusted for: Weeks since vaccinationOR (95% CI), p-value | Adjusted for: Age, sex, weeks since vaccinationOR (95% CI), p-value |
---|---|---|---|---|
Quintile 1 (lowest 20%): 0.4–18 BAU/mL |
32/233 (13.7%) | 3.23 (1.58–6.58), p=0.009 | 2.85 (1.39–5.86), p=0.03 | 2.93 (1.42–6.04), p=0.02 |
Quintile 2: 18–40 BAU/mL | 20/226 (8.8%) | 1.97 (0.92–4.21), p=0.11 | 2.04 (0.94–4.43), p=0.08 | 2.15 (0.99–4.68), p=0.06 |
Quintile 3: 40–73 BAU/mL | 21/239 (8.8%) | 1.95 (0.92–4.15), p=0.11 | 2.26 (1.04–4.92), p=0.06 | 2.41 (1.11–5.27), p=0.04 |
Quintile 4: 73–164 BAU/mL | 21/230 (9.1%) | 2.04 (0.96–4.33), p=0.11 | 2.39 (1.10–5.22), p=0.06 | 2.55 (1.17–5.58), p=0.04 |
Quintile 5 (highest 20%): ≥164 BAU/mL (reference) | 11/234 (4.7%) | 1.00 | 1.00 | 1.00 |